Inflammation and Cancer: I. Rodent models of infectious gastrointestinal and liver cancer

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 3 49-3, 2004, Pages

  Rogers, Arlin B ^a   Fox, James G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Digestive system neoplasms; Helicobacter; Viral hepatitis

Indexed keywords

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER MODEL; CANCER MORTALITY; CANCER RISK; COLON CARCINOGENESIS; COLON CARCINOMA; DIGESTIVE SYSTEM CANCER; DISEASE MODEL; ENTERITIS; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TUMOR; GENETIC ENGINEERING; HELICOBACTER FELIS; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INFECTION; INFLAMMATION; INTESTINE TUMOR; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TUMOR; MALIGNANT TRANSFORMATION; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RAT; REVIEW; STOMACH CANCER; STOMACH TUMOR; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS; WILD TYPE;

EID: 1342322889     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00499.2003     Document Type: Review

References (25)

1. Engle SJ, Ormsby I, Pawlowski S, Boivin GP, Croft J, Balish E, and Doetschman T. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 62: 6362-6366, 2002.
2. Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, and Fox JG. CD4(+) CD25(+) Regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 162: 691-702, 2003.
3. Erdman SE, Rao VP, Poutahidis T, Ihrig MM, Ge Z, Feng Y, Tomczak M, Rogers AB, Horwitz BH, and Fox JG. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Concer Res 63: 6042-6050, 2003.
4. Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, Shi HN, and Nagler-Anderson C. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 6: 536-542, 2000.
5. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, and Roa I. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114: 755-763, 1998.
6. Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, Collins MJ Jr, Gorelick PL, and Ward JM. Helicobacter hepaticus sp nov. a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 32: 1238-1245, 1994.
7. Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, and Murphy JC. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun 64: 1548-1558, 1996.
8. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A, and Wang TC. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 63: 942-950, 2003.
9. Fox JG, Sheppard BJ, Dangler CA, Whary MT, Ihrig M, and Wang TC. Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses. Cancer Res 62: 696-702, 2002.
10. Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N, Dangler CA, Israel DA, Krishna U, Gaus K, and Peek RM Jr. Host and microbial constituents influence Helicobacter pylori-induccd cancer in a murine model of hypergastrinemia. Gastroenterology 124: 1879-1890, 2003.
11. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon. June 7-14, 1994. IARC Monogr Eval Carcinog Risks Hum 61: 1-241, 1994.
12. Koike K. Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. J Gastroenterol 37: 55-64, 2002.
13. Leong RW and Sung JJ. Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16: 1037-1045, 2002.
14. Mast EE, Alter MJ, and Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 17: 1730-1733, 1999.
15. Mueller A, O'Rourke J, Grimm J, Guillemin K, Dixon MF, Lee A, and Falkow S. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci USA 100: 1292-1297, 2003.
16. Newman JV, Kosaka T, Sheppard BJ, Fox JG, and Schauer DB. Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis 184: 227-230, 2001.
17. Peek RM Jr and Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37, 2002.
18. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, and Murray CJ. Global and regional estimates of cancer mortality and incidence by site. II. Results for the global burden of disease 2000. BMC Cancer 2: 37, 2002.
19. Singh M and Kumar V. Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma. Res Med Virol 13: 243-253, 2003.
20. Suerbaum S, Josenhans C, Sterzenbach T, Drescher B, Brandt P, Bell M, Droge M, Fartmann B, Fischer HP, Ge Z, Horster A, Holland R, Klein K, Konig J, Macko L, Mendz GL, Nyakatura G, Schauer DB, Shen Z, Weber J, Frosch M, and Fox JG. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci USA 100: 7901-7906, 2003.
21. Syder AJ, Oh JD, Guruge JL, O'Donnell D, Karlsson M, Mills JC, Bjorkholm BM, and Gordon JI. The impact of parietal cells on Helicobacter pylori tropism and host pathology: an analysis using gnotobiotic normal and transgenic mice. Proc Natl Acad Sci USA 100: 3467-3472, 2003.
22. Tomczak MF, Erdman SE, Poutahidis T, Rogers AB, Holcombe H, Plank B, Fox JG, and Horwitz BH. NF-κB is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J Immunol 171: 1484-1492, 2003.
23. Touati E, Michel V, Thiberge JM, Wuscher N, Huerre M, and Labigne A. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 124: 1408-1419, 2003.
24. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ, and Fox JG. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118: 36-47, 2000.
25. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, Gorelick PL, Nagashima K, Gonda MA, Gilden RV, Tully JG, Russell RJ, Benveniste RE, Paster BJ, Dewhirst FE, Donovan JC, Anderson LM, and Rice JM. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86: 1222-1227, 1994.